Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients - More Patients Included and 90-day Follow up

NCT04593654 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT04593654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04593654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients - More Patients Included and 90-day Follow up
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Completed
Start date
March 1, 2020
Completion date
October 15, 2020
Enrollment
257 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, thromboembolism